Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models

Author： Corthay Alexandre Lundin Katrin Munthe Ludvig Frøyland Marianne Gedde-Dahl Tobias Dembic Zlatko Bogen Bjarne

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.9, 2004-09, pp. : 759-769

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Deletion of Idiotype (Id)-Specific T Cells in Multiple Myeloma

By Bogen Bjarne Schenck Karl Munthe Ludvig A. Dembic Zlatko

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 783-788

Informa Healthcare

Access to resources Recommend Favorite

Management Strategies for Relapsed Multiple Myeloma

By Richardson Paul G. Schlossman Robert Munshi Nikhil Anderson Kenneth

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 393-409

Adis International

Access to resources Recommend Favorite

Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies

Current Cancer Therapy Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 169-183

Bentham Science Publishers

Access to resources Recommend Favorite

Current treatment strategies with lenalidomide in multiple myeloma and future perspectives

By Larocca Alessandra Cavallo Federica Mina Roberto Boccadoro Mario Palumbo Antonio

Future Oncology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1223-1238

Future Medicine

Access to resources Recommend Favorite

Isolation and Expansion of Allogeneic Myeloma-Specific Interferon-Gamma Producing T Cells for Adoptive Immunotherapy

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 377-384

Humana Press, Inc

Access to resources Recommend Favorite